Medicon Hellas S.A.
Research Medicon Hellas S.A. (MEDIC) on Bullrun: market cap EUR 12.64M, P/E 16.7, dividend yield 4.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMEDIC
- ExchangeAT
- CountryGreece
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 12.64M
- P/E16.7
- Dividend yield4.6%
Valuation Snapshot
latest market cap is EUR 12.64M; P/E is 16.7; dividend yield is 4.6%.
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, work flow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology and immunochemistry reagents.
Frequently asked questions
What is Medicon Hellas S.A.'s market cap?
Medicon Hellas S.A.'s market capitalization is EUR 12.64M.
What is Medicon Hellas S.A.'s P/E ratio?
Medicon Hellas S.A.'s price-to-earnings (P/E) ratio is 16.7.
Does Medicon Hellas S.A. pay a dividend?
Medicon Hellas S.A. has a dividend yield of 4.6%.
What does Medicon Hellas S.A. do?
Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally.